Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Genexine, Inc.
  6. Summary
    A095700   KR7095700001

GENEXINE, INC.

(A095700)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
11/30/2021 12/01/2021 12/02/2021 12/03/2021 12/06/2021 Date
57200 57800 59200 60500 60300 Last
225931 113283 139278 99013 112807 Volume
-4.67% +1.05% +2.42% +2.20% -0.33% Change
Estimated financial data (e)
Sales 2019 11 303 M 9,60 M 9,60 M
Net income 2019 -16 509 M -14,0 M -14,0 M
Net cash position 2019 43 139 M 36,6 M 36,6 M
P/E ratio 2019 -80,7x
Yield 2019 -
Sales 2020 18 543 M 15,7 M 15,7 M
Net income 2020 27 570 M 23,4 M 23,4 M
Net Debt 2020 20 441 M 17,4 M 17,4 M
P/E ratio 2020 142x
Yield 2020 -
Capitalization 1 509 B 1 278 M 1 281 M
EV / Sales 2019 128x
EV / Sales 2020 167x
Nbr of Employees 147
Free-Float 79,0%
More Financials
Company
Genexine Inc is a Korea-based company mainly engaged in the research and development of bio pharmaceuticals. The Company operates its business through two segments. The New Drug Development segment engages in human growth hormone, neutropenia treatment, anemia treatment, anticancer immunotherapy, hyFc platform, and other technology transfers. In addition, this segment sells the technical property rights of... 
More about the company
All news about GENEXINE, INC.
09/15INDONESIA IN TALKS WITH WHO TO BECOM : minister
RE
05/17South Korea's Genexine signs COVID-19 vaccine candidate manufacturing deal with Hanmi
RE
05/10Certain Ordinary Shares of I-Mab are subject to a Lock-Up Agreement Ending on 10-MAY-20..
CI
04/12S.Korea to begin producing Novavax COVID-19 vaccine as early as June
RE
01/27PT KALBE FARMA TBK : General Atlantic to invest $55 mln in Indonesia's Kalbe Farma biotech..
RE
01/19Turret Capital Management Signs A Definitive License Agreement with Genexine, Inc
CI
2020ToolGen Incorporated announced that it has received KRW 10.0000004 billion in funding f..
CI
2020ToolGen Incorporated announced that it expects to receive KRW 10.0000004 billion in fun..
CI
2020North Korea-linked hackers targeted J&J, Novavax in hunt for COVID research
RE
2020North Korean Hackers Are Said to Have Targeted Companies Working on Covid-19 Vaccines -..
DJ
2020North Korean Hackers Are Said to Have Targeted Companies Working on Covid-19 Vaccines
DJ
2020Genexine, Inc. and NeoimmuneTech, Inc. Releases Data for Their Phase 1B/2 Study of Gx-I..
CI
2020S.Korea begins preliminary review of AstraZeneca's COVID-19 vaccine candidate
RE
2020FACTBOX : The race for a coronavirus vaccine
RE
2020South Korea's Genexine begins human trial of coronavirus vaccine
RE
More news
News in other languages on GENEXINE, INC.
2020Varios hackers vinculados a Corea del Norte atacan a J&J y Novavax en busca de datos so..
2020Nordkorea soll sechs Covid-Medikamentenentwickler attackiert haben
2020Hackers norcoreanos atacaron a firmas que trabajan en vacunas Covid-19 -Fuentes
More news
Chart GENEXINE, INC.
Duration : Period :
Genexine, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENEXINE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Jung-Won Woo Chief Executive Officer
Yong-MIn Won Chief Financial Officer & Senior Managing Director
Mi-Jung Ahn Independent Director
Tae-Yong Lee Independent Director
Neil K. Warma Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GENEXINE, INC.-51.49%1 278
GILEAD SCIENCES, INC.19.29%87 180
BIONTECH SE310.30%67 585
REGENERON PHARMACEUTICALS29.37%65 347
WUXI APPTEC CO., LTD.21.78%63 017
VERTEX PHARMACEUTICALS-13.24%52 137